Adoptive Immunotherapy Against Allogeneic Kidney Grafts in Dogs with Stable Hematopoietic Trichimerism

[1]  R. Storb,et al.  Principles of peripheral blood mononuclear cell apheresis in a preclinical canine model of hematopoietic cell transplantation. , 2008, Journal of veterinary internal medicine.

[2]  R. Storb,et al.  Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning. , 2007, Blood.

[3]  M. Stegall,et al.  Molecular Evidence of Injury and Inflammation in Normal and Fibrotic Renal Allografts One Year Posttransplant , 2007, Transplantation.

[4]  R. Nash,et al.  Ex Vivo Expanded T Regulatory (Treg) Cells Block Conversion of Mixed Chimeras To Complete Donor Chimerism. , 2006 .

[5]  M. Aglietta,et al.  Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD. , 2006, Blood.

[6]  O. Ringdén,et al.  Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  Gui-ping Li,et al.  Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma. , 2005, World journal of gastroenterology.

[8]  S. Riddell,et al.  Molecules and mechanisms of the graft-versus-leukaemia effect , 2004, Nature Reviews Cancer.

[9]  M. Bishop.  Allogeneic hematopoietic stem cell transplantation for metastatic breast cancer. , 2004, Haematologica.

[10]  J. Falkenburg,et al.  Minor histocompatibility antigens in human stem cell transplantation. , 2003, Experimental hematology.

[11]  R. Storb,et al.  Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras , 2003, Transplantation.

[12]  R. Storb,et al.  Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras1 , 2002, Transplantation.

[13]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[14]  W. Linehan,et al.  Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. , 2000, The New England journal of medicine.

[15]  J. D. Thompson,et al.  Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. , 2000, Blood.

[16]  W. Cook,et al.  Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. , 1999, Transplantation.

[17]  R. Storb,et al.  DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. , 1998, Tissue antigens.

[18]  S. Mackinnon.  11 Donor leukocyte infusions , 1997 .

[19]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. , 1997, Blood.

[20]  P. Matzinger,et al.  Is cancer dangerous to the immune system? , 1996, Seminars in immunology.

[21]  E. Ostrander,et al.  Histocompatibility testing of dog families with highly polymorphic microsatellite markers. , 1996, Transplantation.

[22]  H. Deeg,et al.  Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors , 1996 .

[23]  R. Storb,et al.  Canine models of bone marrow transplantation. , 1990, Laboratory animal science.

[24]  A. Belldegrun,et al.  Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. , 1988, Cancer research.